NEW YORK (GenomeWeb News) – New Delhi-based Super Religare Laboratories will distribute Rosetta Genomics’ three microRNA-based cancer tests in India, Saudi Arabia, Qatar, and United Arab Emirates, Rosetta said today.

SRL will send the samples from the four countries to Rosetta Genomics’ CLIA-certified lab in Philadelphia for analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

In Genome Biology this week: miRNAs linked to diffuse large B-cell lymphoma outcomes, database of bird genomes, and more.